Important milestones in cardiac regenerative medicine that will define future research were reached in 2017: demonstration of adult cardiomyocyte renewal capacity, recognition of the importance of the extracellular matrix and the higher regenerative efficacy of repetitive dose protocols, and the publication of human data supporting paracrine effects of stem cell therapies and guidelines from TACTICS, the first international alliance on cardiac regenerative medicine.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lázár, E., Sadek, H. A. & Bergmann, O. Cardiomyocyte renewal in the human heart: insights from the fall-out. Eur. Heart J. 38, 2333–2342 (2017).
Wang, W. E. et al. Dedifferentiation, proliferation, and redifferentiation of adult mammalian cardiomyocytes after ischemic injury. Circulation 136, 834–848 (2017).
Bassat, E. et al. The extracellular matrix protein agrin promotes heart regeneration in mice. Nature 547, 179–184 (2017).
Guo, Y. et al. Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res. Cardiol. 112, 18 (2017).
Wollert, K. C. et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial. Eur. Heart J. 38, 2936–2943 (2017).
Fernández-Avilés, F. et al. Global position paper on cardiovascular regenerative medicine. Eur. Heart J. 38, 2532–2546 (2017).
Acknowledgements
The author thanks Andreu Climent, Ricardo Sanz-Ruiz, and Ana Fernández-Baza for their outstanding contribution to this work. F.F.-A. is supported by grants from the Spanish Ministry of Science and Innovation (RTC-2015–4398, RTC- 2016–4911), Instituto de Salud Carlos III (PI13- 01882 and PI16-01123), Red de Investigación Cardiovascular (RIC. RD12.0042.0001), Red de Terapia Celular (TERCEL. RD12.0019.0021), and CIBERCV (CB16-11-00292), and is co-financed with FEDER funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Related links
FURTHER INFORMATION
PowerPoint slides
Rights and permissions
About this article
Cite this article
Fernández-Avilés, F. Novel paradigms in the fight against heart failure. Nat Rev Cardiol 15, 73–74 (2018). https://doi.org/10.1038/nrcardio.2017.218
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2017.218
This article is cited by
-
Inflammation and fibrosis in murine models of heart failure
Basic Research in Cardiology (2019)